Recent Events & Catalysts

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Yahoo · today

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Yahoo · today

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada

Yahoo · today

Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million

Yahoo · today

Can BMY's CELMoD Program Advancements Strengthen Its Oncology Portfolio?

Yahoo · 1d ago

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Yahoo · 1d ago

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

Yahoo · 1d ago

Agilent Receives FDA Approval For The PD‑L1 LHC 28‑8 PharmDx Assay As Companion Diagnostic To Identify Patients With Carcinomas Who May Be Eligible For Treatment With OPDIVO or OPDIVO QVANTIG

Benzinga · 1d ago

Submission of matters to a vote of security holders

Filed 2026-05-08 · 68d ago

Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits

Filed 2026-04-30 · 76d ago · Material